Cargando…

Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients

STUDY DESIGN: Retrospective survey. OBJECTIVES: Purpose of this study was to explore whether bowel and bladder management can be influenced by locomotion therapy with HAL Robot Suit. METHODS: 35 subjects with acute (< one year since injury, n = 13) or chronic (> one year since injury, n = 22)...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkemper, Alexis, Grasmücke, Dennis, Yilmaz, Emre, Reinecke, Felix, Schildhauer, Thomas Armin, Aach, Mirko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240584/
https://www.ncbi.nlm.nih.gov/pubmed/33858209
http://dx.doi.org/10.1177/21925682211003851
_version_ 1785053794685419520
author Brinkemper, Alexis
Grasmücke, Dennis
Yilmaz, Emre
Reinecke, Felix
Schildhauer, Thomas Armin
Aach, Mirko
author_facet Brinkemper, Alexis
Grasmücke, Dennis
Yilmaz, Emre
Reinecke, Felix
Schildhauer, Thomas Armin
Aach, Mirko
author_sort Brinkemper, Alexis
collection PubMed
description STUDY DESIGN: Retrospective survey. OBJECTIVES: Purpose of this study was to explore whether bowel and bladder management can be influenced by locomotion therapy with HAL Robot Suit. METHODS: 35 subjects with acute (< one year since injury, n = 13) or chronic (> one year since injury, n = 22) incomplete paraplegia (American Spinal Injury Association Impairment Scale (AIS) B, n = 1 / AIS C, n = 22 / AIS D, n = 7) or complete paraplegia (AIS A, n = 5) with zones of partial preservation (ZPP) participated. A retrospective survey was carried out asking for bowel incontinence (Wexner Score), constipation (Cleveland Clinic Constipation Scoring System (CCCS)) and bladder function (self-developed questionnaire) before and after completing a training period of 12 weeks with HAL. RESULTS: Wexner Score over all patients and for group of chronic patients decreased significantly. For group of acute patients Wexner Score decreased insignificantly. Patients from both groups with higher baseline scores could decrease significantly. CCCS was insignificantly reduced for all patients, group of acute and group of chronic patients. For subgroup of chronic patients with higher baseline scores, CCCS decreased at end of training period missing out significance. The self-developed questionnaire showed an improvement in bladder function in 28.24% of all patients, 31.43% of chronic patients, and 23.08% of acute patients. CONCLUSIONS: Our findings show trends of enhanced bladder and bowel function following exoskeleton training. Patients with higher baseline scores in Wexner Score and CCCS seem to benefit more than those with mild to moderate scores.
format Online
Article
Text
id pubmed-10240584
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102405842023-06-06 Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients Brinkemper, Alexis Grasmücke, Dennis Yilmaz, Emre Reinecke, Felix Schildhauer, Thomas Armin Aach, Mirko Global Spine J Original Articles STUDY DESIGN: Retrospective survey. OBJECTIVES: Purpose of this study was to explore whether bowel and bladder management can be influenced by locomotion therapy with HAL Robot Suit. METHODS: 35 subjects with acute (< one year since injury, n = 13) or chronic (> one year since injury, n = 22) incomplete paraplegia (American Spinal Injury Association Impairment Scale (AIS) B, n = 1 / AIS C, n = 22 / AIS D, n = 7) or complete paraplegia (AIS A, n = 5) with zones of partial preservation (ZPP) participated. A retrospective survey was carried out asking for bowel incontinence (Wexner Score), constipation (Cleveland Clinic Constipation Scoring System (CCCS)) and bladder function (self-developed questionnaire) before and after completing a training period of 12 weeks with HAL. RESULTS: Wexner Score over all patients and for group of chronic patients decreased significantly. For group of acute patients Wexner Score decreased insignificantly. Patients from both groups with higher baseline scores could decrease significantly. CCCS was insignificantly reduced for all patients, group of acute and group of chronic patients. For subgroup of chronic patients with higher baseline scores, CCCS decreased at end of training period missing out significance. The self-developed questionnaire showed an improvement in bladder function in 28.24% of all patients, 31.43% of chronic patients, and 23.08% of acute patients. CONCLUSIONS: Our findings show trends of enhanced bladder and bowel function following exoskeleton training. Patients with higher baseline scores in Wexner Score and CCCS seem to benefit more than those with mild to moderate scores. SAGE Publications 2021-04-16 2023-04 /pmc/articles/PMC10240584/ /pubmed/33858209 http://dx.doi.org/10.1177/21925682211003851 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Brinkemper, Alexis
Grasmücke, Dennis
Yilmaz, Emre
Reinecke, Felix
Schildhauer, Thomas Armin
Aach, Mirko
Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title_full Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title_fullStr Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title_full_unstemmed Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title_short Influence of Locomotion Therapy With the Wearable Cyborg HAL on Bladder and Bowel Function in Acute and Chronic SCI Patients
title_sort influence of locomotion therapy with the wearable cyborg hal on bladder and bowel function in acute and chronic sci patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240584/
https://www.ncbi.nlm.nih.gov/pubmed/33858209
http://dx.doi.org/10.1177/21925682211003851
work_keys_str_mv AT brinkemperalexis influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients
AT grasmuckedennis influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients
AT yilmazemre influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients
AT reineckefelix influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients
AT schildhauerthomasarmin influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients
AT aachmirko influenceoflocomotiontherapywiththewearablecyborghalonbladderandbowelfunctioninacuteandchronicscipatients